341 related articles for article (PubMed ID: 30857543)
1. Exploring the heterogeneity of human exposure to malaria vectors in an urban setting, Bouaké, Côte d'Ivoire, using an immuno-epidemiological biomarker.
Traoré DF; Sagna AB; Adja AM; Zoh DD; Adou KA; Lingué KN; Coulibaly I; Tchiekoi NB; Assi SB; Poinsignon A; Dagnogo M; Remoue F
Malar J; 2019 Mar; 18(1):68. PubMed ID: 30857543
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Malaria Urban Risk Using an Immuno-Epidemiological Biomarker of Human Exposure to
Traoré DF; Sagna AB; Adja AM; Zoh DD; Lingué KN; Coulibaly I; N'Cho Tchiekoi B; Assi SB; Poinsignon A; Dagnogo M; Remoue F
Am J Trop Med Hyg; 2018 May; 98(5):1353-1359. PubMed ID: 29512479
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium falciparum infection during dry season: IgG responses to Anopheles gambiae salivary gSG6-P1 peptide as sensitive biomarker for malaria risk in Northern Senegal.
Sagna AB; Gaayeb L; Sarr JB; Senghor S; Poinsignon A; Boutouaba-Combe S; Schacht AM; Hermann E; Faye N; Remoue F; Riveau G
Malar J; 2013 Aug; 12():301. PubMed ID: 23988032
[TBL] [Abstract][Full Text] [Related]
4. Preliminary validation of the use of IgG antibody response to Anopheles gSG6-p1 salivary peptide to assess human exposure to malaria vector bites in two endemic areas of Cameroon in Central Africa.
Cheteug G; Elanga-Ndille E; Donkeu C; Ekoko W; Oloume M; Essangui E; Nwane P; NSango SE; Etang J; Wanji S; Ayong L; Eboumbou Moukoko CE
PLoS One; 2020; 15(12):e0242510. PubMed ID: 33382730
[TBL] [Abstract][Full Text] [Related]
5. Variation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands.
Badu K; Siangla J; Larbi J; Lawson BW; Afrane Y; Ong'echa J; Remoue F; Zhou G; Githeko AK; Yan G
Malar J; 2012 Sep; 11():318. PubMed ID: 22963464
[TBL] [Abstract][Full Text] [Related]
6. Utility of plasma anti-gSG6-P1 IgG levels in determining changes in Anopheles gambiae bite rates in a rural area of Cameroon.
Nguetsa GC; Elanga-Ndille E; Essangui Same EG; Nganso Keptchouang T; Mandeng SE; Ekoko Eyisap W; Binyang JA; Fogang B; Nouage L; Piameu M; Ayong L; Etang J; Wanji S; Eboumbou Moukoko CE
Sci Rep; 2024 Jun; 14(1):14294. PubMed ID: 38906949
[TBL] [Abstract][Full Text] [Related]
7. Pattern of antibody responses to Plasmodium falciparum antigens in individuals differentially exposed to Anopheles bites.
Aka KG; Traoré DF; Sagna AB; Zoh DD; Assi SB; Tchiekoi BN; Adja AM; Remoue F; Poinsignon A
Malar J; 2020 Feb; 19(1):83. PubMed ID: 32085710
[TBL] [Abstract][Full Text] [Related]
8. Spatial Assessment of Contact Between Humans and Anopheles and Aedes Mosquitoes in a Medium-Sized African Urban Setting, Using Salivary Antibody-Based Biomarkers.
Sagna AB; Kassié D; Couvray A; Adja AM; Hermann E; Riveau G; Salem G; Fournet F; Remoue F
J Infect Dis; 2019 Aug; 220(7):1199-1208. PubMed ID: 31152664
[TBL] [Abstract][Full Text] [Related]
9. IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal.
Drame PM; Machault V; Diallo A; Cornélie S; Poinsignon A; Lalou R; Sembène M; Dos Santos S; Rogier C; Pagès F; Le Hesran JY; Remoué F
Malar J; 2012 Mar; 11():72. PubMed ID: 22424570
[TBL] [Abstract][Full Text] [Related]
10.
Ya-Umphan P; Cerqueira D; Cottrell G; Parker DM; Fowkes FJI; Nosten F; Corbel V
Am J Trop Med Hyg; 2018 Aug; 99(2):350-356. PubMed ID: 29869601
[TBL] [Abstract][Full Text] [Related]
11. Uneven malaria transmission in geographically distinct districts of Bobo-Dioulasso, Burkina Faso.
Soma DD; Kassié D; Sanou S; Karama FB; Ouari A; Mamai W; Ouédraogo GA; Salem G; Dabiré RK; Fournet F
Parasit Vectors; 2018 May; 11(1):296. PubMed ID: 29751825
[TBL] [Abstract][Full Text] [Related]
12. Entomological drivers of uneven malaria transmission in urban lowland areas in Bouaké, Côte d'Ivoire.
Dahoui MMC; Adou KA; Coulibaly B; Niamien KL; Koné A; Cornelie S; Zoh DD; Assouho KF; Moiroux N; Adja AM; Fournet F
Malar J; 2023 Jan; 22(1):34. PubMed ID: 36717848
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal analysis of antibody responses in symptomatic malaria cases do not mirror parasite transmission in peri-urban area of Cote d'Ivoire between 2010 and 2013.
Koffi D; Varela ML; Loucoubar C; Beourou S; Vigan-Womas I; Touré A; Djaman JA; Touré AO; Perraut R
PLoS One; 2017; 12(2):e0172899. PubMed ID: 28245264
[TBL] [Abstract][Full Text] [Related]
14. Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites.
Poinsignon A; Cornelie S; Ba F; Boulanger D; Sow C; Rossignol M; Sokhna C; Cisse B; Simondon F; Remoue F
Malar J; 2009 Aug; 8():198. PubMed ID: 19674487
[TBL] [Abstract][Full Text] [Related]
15. Human IgG responses to Aedes mosquito salivary peptide Nterm-34kDa and its comparison to Anopheles salivary antigen (gSG6-P1) IgG responses measured among individuals living in Lower Moshi, Tanzania.
Kassam NA; Laswai D; Kulaya N; Kaaya RD; Kajeguka DC; Schmiegelow C; Wang CW; Alifrangis M; Kavishe RA
PLoS One; 2022; 17(10):e0276437. PubMed ID: 36301860
[TBL] [Abstract][Full Text] [Related]
16. gSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areas.
Sagna AB; Sarr JB; Gaayeb L; Drame PM; Ndiath MO; Senghor S; Sow CS; Poinsignon A; Seck M; Hermann E; Schacht AM; Faye N; Sokhna C; Remoue F; Riveau G
Parasit Vectors; 2013 Mar; 6():68. PubMed ID: 23497646
[TBL] [Abstract][Full Text] [Related]
17. Use of anti-gSG6-P1 IgG as a serological biomarker to assess temporal exposure to Anopheles' mosquito bites in Lower Moshi.
Kassam NA; Kulaya N; Kaaya RD; Schmiegelow C; Wang CW; Kavishe RA; Alifrangis M
PLoS One; 2021; 16(10):e0259131. PubMed ID: 34705869
[TBL] [Abstract][Full Text] [Related]
18. Diversity of
Adja AM; Zoh DD; Sagna AB; Kpan DMS; Guindo-Coulibaly N; Yapi A; Chandre F
Vector Borne Zoonotic Dis; 2021 Aug; 21(8):593-601. PubMed ID: 34129392
[TBL] [Abstract][Full Text] [Related]
19. Wide cross-reactivity between Anopheles gambiae and Anopheles funestus SG6 salivary proteins supports exploitation of gSG6 as a marker of human exposure to major malaria vectors in tropical Africa.
Rizzo C; Ronca R; Fiorentino G; Mangano VD; Sirima SB; Nèbiè I; Petrarca V; Modiano D; Arcà B
Malar J; 2011 Jul; 10():206. PubMed ID: 21794142
[TBL] [Abstract][Full Text] [Related]
20. IgG antibody responses to Anopheles gambiae gSG6-P1 salivary peptide are induced in human populations exposed to secondary malaria vectors in forest areas in Cameroon.
Ndo C; Elanga-Ndille E; Cheteug G; Metitsi RD; Wanji S; Moukoko CEE
PLoS One; 2022; 17(11):e0276991. PubMed ID: 36355922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
